
|Articles|April 15, 2008
Medivir, GlaxoSmithKline enter co-promotion agreement
Stockholm, Sweden - Medivir has entered into a co-promotion agreement with the Swedish subsidiary of GlaxoSmithKline, according to Earthtimes.org.
Advertisement
Stockholm, Sweden
- Medivir has entered into a co-promotion agreement with the Swedish subsidiary of GlaxoSmithKline, according to Earthtimes.org.
The agreement will allow Medivir to co-promote some GlaxoSmithKline products on the Swedish market, such as the companies entire dermatology portfolio, including the eczema and psoriasis drug Betnovat.
The magnitude of revenue for Medivir is based on the degree that future sales exceed an agreed baseline, Earthtimes reports.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











